Article Details
Retrieved on: 2024-01-18 19:30:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The board of directors of Beijing Luzhu Biotechnology Co., Ltd. announced that LZ901, the core product of the Group, has completed the enrollment ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here